Thalidomide: lack of mutagenic activity across phyla and genetic endpoints (Q50132461)

25 February 2018

title

Thalidomide: lack of mutagenic activity across phyla and genetic endpoints (English)

1 reference

25 February 2018

0 references

Ashby J

1

1 reference

25 February 2018

Tinwell H

2

1 reference

25 February 2018

Callander RD

3

1 reference

25 February 2018

Kimber I

4

1 reference

25 February 2018

Clay P

5

1 reference

25 February 2018

Galloway SM

6

1 reference

25 February 2018

Hill RB

7

1 reference

25 February 2018

Greenwood SK

8

1 reference

25 February 2018

Gaulden ME

9

1 reference

25 February 2018

Ferguson MJ

10

1 reference

25 February 2018

Vogel E

11

1 reference

25 February 2018

Nivard M

12

1 reference

25 February 2018

Parry JM

13

1 reference

25 February 2018

Williamson J

14

1 reference

25 February 2018

language of work or name

English

0 references

publication date

1 December 1997

1 reference

25 February 2018

published in

Mutation Research

1 reference

25 February 2018

volume

396

1 reference

25 February 2018

issue

1-2

1 reference

25 February 2018

page(s)

45-64

1 reference

25 February 2018

Thalidomide may be a mutagen

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

THALIDOMIDE AND CONGENITAL ABNORMALITIES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Thalidomide as a mutagenic agent in the mosquito (Culex pipiens molestus).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Detection of chemical mutagens by the dominant lethal assay in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Thalidomide may be a mutagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Thalidomide may not be a mutagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Is thalidomide mutagenic?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Weak mutagenicity to Salmonella of the formaldehyde-releasing anti-tumour agent hexamethylmelamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Comparison of acridine orange and Giemsa stains in several mouse bone marrow micronucleus assays--including a triple dose study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Revised methods for the Salmonella mutagenicity test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

The effects of pre-incubation period and norharman on the mutagenic potency of 4-dimethylaminoazobenzene and 3'-methyl-4-dimethylaminoazobenzene in S. typhimurium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

The hair-dye reagent 2-(2′,4′-diaminophenoxy)ethanol is mutagenic to Salmonella typhimurium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Human liver S-9 metabolic activation: proficiency in cytogenetic assays and comparison with phenobarbital/beta-naphthoflavone or aroclor 1254 induced rat S-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Thalidomide teratogenesis: evidence for a toxic arene oxide metabolite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

A modified protocol for the cytochalasin B in vitro micronucleus assay using whole human blood or separated lymphocyte cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Evaluation of phenobarbital/beta-naphthoflavone as an alternative S9-induction regime to Aroclor 1254 in the rat for use in in vitro genotoxicity assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Performance of 181 chemicals in a Drosophila assay predominantly monitoring interchromosomal mitotic recombination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

The efficient preparation of corn oil suspensions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Genetic toxicity and potential carcinogenicity of taxol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Potent clastogenicity of the human carcinogen etoposide to the mouse bone marrow and mouse lymphoma L5178Y cells: comparison to Salmonella responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Inactivity of methylene chloride in the mouse bone marrow micronucleus assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

The murine local lymph node assay: a commentary on collaborative studies and new directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Chromosomal breakage and teratogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

CHROMOSOME ABERRATIONS IN HUMAN CELLS INDUCED BY THALIDOMIDE IN VITRO: PRELIMINARY REPORT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Spontaneous micronuclei in peripheral blood erythrocytes from 35 mammalian species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Thalidomide and Neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

ACTION OF THALIDOMIDE ON RADICAL MERISTEMS OF ALLIUM CEPA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Studies on the cytological effects of thalidomide and its hydrolytic products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

IPCS harmonization of methods for the prediction and quantification of human carcinogenic/mutagenic hazard, and for indicating the probable mechanism of action of carcinogens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Selecting chemicals and assays for assessing mammalian germ cell mutagenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Thalidomide and congenital abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Micronucleus morphology as a means to distinguish aneugens and clastogens in the mouse bone marrow micronucleus assay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

The detection and assessment of the aneugenic potential environmental chemicals: the European Community Aneuploidy Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

Mechanistic relationship among mutagenicity, skin sensitization, and skin carcinogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2897%2900174-7

10.1016/S0027-5107(97)00174-7

7 January 2021

Identifiers

DOI

1 reference

25 February 2018

1 reference

25 February 2018